A first-of-its-kind trial studies the use of injectable buprenorphine to treat methamphetamine use disorder and opioid co-use

OAKLAND, Calif., June 28, 2023 /PRNewswire/ — Investigators at Alameda Health System’s (AHS) Bridge Clinic are participating in a new, six-city trial of injectable buprenorphine for the treatment of methamphetamine use disorder in adults who also use opioids. This is the first study to…

Click here to view original post